Archiwum hase³
satisfactory therapeutic result | intralesional triamcinolone injections | triamcinolone injections | hypertrophic lichen planus | chronic cholestatic pruritus | depressive symptoms | ectomy | one strained RNA molecules | left temporal lobe | insula | oligoastrocytoma | pseudopodium | oligodendrocyte | homolateral | ramus | edentulism | gingival crevice | transpeptidase | extragenital localization | extragenital lichen sclerosus | ivory-colored plaque | postinflammatory hiperpigmentation | postinflammatory hipopigmentation | ultra potent corticosteroids | pemphigus vegetans | non-desmoglein antigens | Classification of Diseases and Related Health Problems | dysfunction of the brain | persistent delusional disorder | hypochondriacal disorders | lowered self-esteem | suicidal attempts | cosmetology | signal peptides | low molecular signal peptides | firmness of the skin | desmoglein antigens | drug-mediated pemphigus | pemphigus herpetiformis | pemphigus paraneoplastic | implant surface | pristine | suturing | saucerization | soft diet | pathognomonic | quantitative mycological stool examination | probiotic supplementation | cytokine profile | overactivity | anti-inflammatory agents | pro-inflammatory agents | Crohn`s disease activity Index | pediatric Crohn's disease activity index | structural and functional epithelial integrity | microbiota | hypothalamus-pituitary-adrenal axis | enteric immunological system | intestinal microbiota | primary biliary cirrhosis {PBC} | antimitochondrial autoantibodies | preductopenic wariant (of primary biliary cirrhosis) | forms of primary biliary cirrhosis {PBC} | cationic trypsinogen | progressive fibrosis | exocrine function | endocrine function | chronic relapsing pancreatitis | pancreatic stone protein | necrosis Balseri | familial autosomal dominant form of Alzheimer`s disease | minimally invasive technique | simple hepatic cysts | peripheral dopamine D2 receptors | prokinetic effect | epigastric pain syndrome {EPS} | gender preferences | endoscopist | screening colonoscopy | colorectal cancer screening | treatment of choice | mucositis | head and neck cancer | supplement of the surgical treatment | supplement of the systemic treatment | precision and safety of treatment | local complications | systemic complications | xerostomia | bone necrosis | serious clinical problem | postradiation reaction | post radiation caries | oral mucositis | osteoradionecrosi | colon cancer | neoplasm of the colon and rectum | fatty acid synthase {FAS} | malignant cells | lipid components of cellular membranes | intraductal papillary mucinous neoplasm of the pancreas | poorly differentiated pancreatic cancer | hepatic cyst | intrahepatic biliary ducts | proliferation of malignant cells | method of choice | spinal cord stimulation | accessory parotid gland | gastric blood flow | pathognomonic symptoms | wide spectrum of symptoms | capsule endoscopy | perioperative management | primary transplantations | retransplantations | end stage liver disease | graft survival | xenin | energy balance disorders | mean plasma xenin concentration | trochanter major | immunodeficiecy | paraspinal | rongeurs | pedicle | auto-immunological diseases | tardive complications | dysfunctions of the respiratory system | microangiopathy of pulmonary vessels | vegetative neuropathy of the respiratory system | forced expiratory volume in the 1st second {FEV1} | forced expiratory vital capacity (FVC EX | peak expiratory flow {PEF} | Kruskal-Wallis test | Mann-Whitney test | therapeutic coefficient | steroidal coefficient | urine steroid profile | bone age | proper body structure | auxological parameters | xenin concentration | sensory nerve | virucide | antiviral | body composition | body composition analysis | population study | bioelectrical impedance | skinfolds | Durnin and WomersleyÂ’s equation | monogenic diabetes | thiamine-responsive megaloblastic anaemia (TRMA) | syndromic form | Thiamine-responsive megaloblastic anaemia syndrome | vitamin-dependent monogenic diabetes | glucokinase gene | continuous subcutaneous insulin infusion | personal insulin pump | double mutation in the glucokinase gene | neonatal diabetes | antiviral drug; | open label trial | permanent neonatal diabetes | hypotrophy | vital capacity {VC} | virucide | antiviral drug; | childhood obesity | diabetes insipidus {DI} | cranial hypertension | vision disorders | aerobic capacity | long-term efforts | physiological cost | locomotion efforts | mechanical treadmill | breathing frequency | oxygen intake | socioeconomic status | autoimmunity | IgA deficiency | selective immunoglobulin A deficiency {sIgAD} | prophylactic effect | fungal endophytes | β-tubulin gene sequence | host plant | endophytic fungal metabolites | potato dextrose broth medium | zone of inhibition | minimum inhibitory concentrations | antifungal therapy | glucosinolates | antropopathogenic fungi | resistance of antropopathogenic fungi | minimal inhibition concentration {MIC} | disk-diffusion method | skin mycoses | climatic zone | multifocal mycosis |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
